Kraig Biocraft Laboratories Expands R&D Capacity for Spider Silk Breakthroughs

Got story updates? Submit your updates here. ›

Kraig Biocraft Laboratories, a leader in spider silk technology, has significantly expanded its research and development capacity to keep pace with rapid progress in its Project Atlas advanced materials initiative. The company has onboarded new scientific personnel, deployed new advanced equipment, and roughly tripled its screening throughput, allowing the R&D team to quickly identify and advance promising new transgenic spider silk lines.

Why it matters

Kraig Labs' spider silk innovations have the potential for industrial and defense applications, and the company is working to maintain its leadership position in this emerging field. The expanded R&D capacity will help the company capitalize on breakthroughs from Project Atlas and bring new advanced biomaterials to market faster.

The details

The recently commissioned equipment streamlines the screening of newly created transgenic lines and the analysis of their resulting spider silk expression levels. Project Atlas is now generating significant numbers of transgenics and potential candidates for new production materials. By automating portions of the testing workflow, Kraig Labs can now rapidly process and evaluate significantly more samples, quickly identifying new, exciting transgenics.

• Kraig Labs implemented these upgrades in direct response to the rapid technical progress made under Project Atlas.
• The Company's research and development capacity has roughly tripled in recent months.

What they’re saying

What’s next

Kraig Labs expects the expanded R&D capacity to shorten development timelines and improve its ability to identify breakthrough material candidates from Project Atlas.